ClinicalLeveraging IRL201104, a Tolerogenic Molecule that Induces Treg & Breg Activation to Restore Immune Homeostasis in Patients with Allergies
Time: 2:00 pm
day: Day 2 Treg Modulators Track PM
Details:
- Investigating IRL2011104 – antigen presenting cell binding pathways to effector cell and inflammatory cytokine regulation
- Targeting ‘upstream’ antigen presenting cells to restore homeostasis and enhance remission outcomes
- Showcasing clinical successes to inform Phase 2b IV studies